Allarity Therapeutics Announces SPAC Allarity Acquisition Corp. Filed Form S-1 For $100M IPO, Up To $115M With Over-Allotment; Sponsor Subsidiary To Own About 25%
Share
Why It Matters
Allarity Therapeutics is raising about $100 million to $115 million from selling new shares to the public, kind of like getting a big loan to grow the company. When a company raises money this way, watch if they use it wisely to make better medicines or if problems pop up.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.